Advertisement

We need your help now

Support from readers like you keeps The Journal open.

You are visiting us because we have something you value. Independent, unbiased news that tells the truth. Advertising revenue goes some way to support our mission, but this year it has not been enough.

If you've seen value in our reporting, please contribute what you can, so we can continue to produce accurate and meaningful journalism. For everyone who needs it.

PA
covid19

EU Commission agrees delivery top-up with Pfizer/BioNTech - Ireland to receive additional 110,000 doses in second quarter

The agreement would see an additional 10 million doses being delivered to member states over the next three months.

LAST UPDATE | 16 Mar 2021

THE EUROPEAN COMMISSION has agreed a top-up to vaccine deliveries for the second quarter of the year with pharmaceutical companies Pfizer and BioNTech. 

Commission President Ursula von der Leyen this morning announced the agreement which involves an accelerated delivery of an additional 10 million doses over the next three months.

This will bring the total EU deliveries of this vaccine to 200 million for that quarter.

Ireland’s share of that (around 1.1%) will be more than two million doses. 

Today’s top-up of 10 million will result in an additional 110,000 doses of the Pfizer/BioNTech vaccine in Ireland in Q2. 

Von der Leyen said this will give member states room to manoeuvre and possibly fill gaps in deliveries. 

“I know how critical Quarter 2 is for the roll-out of our vaccination strategies in member states,” she said. 

These additional doses are to be drawn forward from the option of 100 million doses in the second contract with Pfizer/BioNTech, foreseen for the third and fourth quarters of this year. 

The proposal from the Commission will now go forward for approval by member states in the joint steering board. 

Your Voice
Readers Comments
36
This is YOUR comments community. Stay civil, stay constructive, stay on topic. Please familiarise yourself with our comments policy here before taking part.
Leave a Comment
    Submit a report
    Please help us understand how this comment violates our community guidelines.
    Thank you for the feedback
    Your feedback has been sent to our team for review.

    Leave a commentcancel